Deutsch English Français

Contact

EP1545522

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1545522

EP1545522 - USE OF VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 19.10.2007 Database last updated on 18.11.2024
Most recent event Tooltip	19.10.2007	Application deemed to be withdrawn	published on 21.11.2007 [2007/47]
Applicant(s)	For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN / GB
	[N/P]
Former [2005/26]	For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex UB6 ONN / GB
Inventor(s)	01 / DAVIS, John Beresford, GlaxoSmithKline New Frontiers Science Park South, Third Avenue Harlow, Essex CM19 5AW / GB
	02 / WINCHESTER, Wendy Joyce, GlaxoSmithKline New Frontiers Science Park South, Third Avenue Harlow, Essex CM19 5AW / GB
	[2005/26]
Representative(s)	Rutter, Keith GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB
	[N/P]
Former [2005/26]	Rutter, Keith, Dr. GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB
Application number, filing date	03795018.5	10.09.2003
	[2005/26]
	WO2003EP10261
Priority number, date	GB20020021157	12.09.2002 Original published format: GB 0221157
	[2005/26]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2004024154
	Date:	25.03.2004
	Language:	EN
	[2004/13]
	Type:	A1 Application with search report
	No.:	EP1545522
	Date:	29.06.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 25.03.2004 takes the place of the publication of the European patent application.
	[2005/26]
Search report(s)	International search report - published on:	EP	25.03.2004
Classification	IPC:	A61K31/4439, A61K45/00, A61P1/00, A61P13/00, A61P29/00	[2005/26]
	CPC:	A61K31/4439 (EP,US); A61P1/00 (EP); A61P13/00 (EP); A61P29/00 (EP); A61P43/00 (EP)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/26]
Extension states	AL	Not yet paid
	LT	02.03.2005
	LV	02.03.2005
	MK	Not yet paid
Title	German:	VERWENDUNG EINES VANILLOID-REZEPTOR-ANTAGONISTEN ZUR BEHANDLUNG VON SCHMERZEN	[2005/26]
	English:	USE OF VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN	[2005/26]
	French:	UTILISATION D'UN ANTAGONISTE DU RECEPTEUR VANILLOIDE POUR TRAITER LA DOULEUR	[2005/26]
Entry into regional phase	02.03.2005	National basic fee paid
	02.03.2005	Designation fee(s) paid
	02.03.2005	Examination fee paid
Examination procedure	22.03.2004	Request for preliminary examination filed International Preliminary Examining Authority: EP
	02.03.2005	Examination requested [2005/26]
	15.11.2006	Despatch of a communication from the examining division (Time limit: M06)
	29.05.2007	Application deemed to be withdrawn, date of legal effect [2007/47]
	03.07.2007	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/47]
Fees paid	Renewal fee
	05.09.2005	Renewal fee patent year 03
	08.09.2006	Renewal fee patent year 04
	05.09.2007	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XD]WO0208221 (NEUROGEN CORP [US], et al) [XD] 1,7-11 * page 1 - page 37 * * in particular p. 32, claim 192 *;
		[XD]WO0216317 (PACIFIC CORP [KR], et al) [XD] 1,4,7,9-11 * page 1 - page 7 * * page 24, line 8 - line 13 * * in particular p. 4 * * page 93, line 8 * * page 95, line 11 - page 96, line 2 * * claims *;
		[X]WO9963986 (RECKITT & COLMANN PROD LTD [GB], et al) [X] 1,4-7,9-11 * page 5, line 13 - page 6, line 2 *;
		[DPX]WO03022809 (SMITHKLINE BEECHAM PLC [GB], et al) [DPX] 1-11 * page 2 - page 10 * * page 33 * * page 15, line 15 - line 32 * * example 1 *;
		[DPX]WO03053945 (SMITHKLINE BEECHAM PLC [GB], et al) [DPX] 1-11 * page 2 - page 5 * * page 10, line 17 - line 33 *;
		[PX]WO03068749 (GLAXO GROUP LTD [GB], et al) [PX] 1-11 * page 2, line 26 - page 21 * * page 33, line 5 - line 33 *;
		[DPX]WO02072536 (SMITHKLINE BEECHAM PLC [GB], et al) [DPX] 1-11 * page 1 - page 3 * * page 4, line 36 - page 5, line 8 *;
		[DPX]WO02090326 (SMITHKLINE BEECHAM PLC [GB], et al) [DPX] 1-11 * page 1 - page 3 * * page 5, line 24 - line 36 *
		[X] - BORTOLOTTI M ET AL, "The treatment of functional dyspepsia with red pepper", ALIMENTARY PHARMACOLOGY AND THERAPEUTICS, (200206), vol. 16, no. 6, ISSN 0269-2813, pages 1075 - 1082, XP001157342 [X] 1,4-7,9-11 * the whole document * DOI: http://dx.doi.org/10.1046/j.1365-2036.2002.01280.x
		[X] - LAZZERI M ET AL, "Intravesical capsaicin for treatment of severe bladder pain: A randomized placebo controlled study", JOURNAL OF UROLOGY, (1996), vol. 156, no. 3, ISSN 0022-5347, pages 947 - 952, XP009024463 [X] 1,7,9-11 * the whole document * DOI: http://dx.doi.org/10.1016/S0022-5347(01)65669-6

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p